Diagnosing Alzheimer's disease
Alzheimer's disease is a devastating condition that can be very difficult to detect. The only true way that we have of diagnosing the condition is to perform an autopsy and note the presence of amyloid plaque in the brain - it's a type of abnormal growth that is only present in those with an Alzheimer's condition. Since this is hardly helpful for diagnosing the disease, since it can only be checked for after a person has died, doctors employ several methods of testing to ensure that Alzheimer's disease is present. Doctor's cannot give a surefire diagnosis of Alzheimer's, but through the use of tests, they can often rule out any other type of mental disorder that may be causing the problem. In this article, we'll try to explain some of the tests that doctors use to pin down the cause of a mental problem.
One of the most important tests in a doctor's repertoire for checking for Alzheimer's disease is a mental examination. Doctors can better determine a patient's mental abilities by subjecting them to tests that require them to focus on thinking through difficult questions. They will test the patient's ability to keep their attention focused, and their ability to learn properly. They will also examine a patient's ability to recall information and give them tests of language. The doctors will then compare the patient's test results to test results from other people around their age and education level. If the patient appears to be an outlier, they may be at risk for Alzheimer's.
Another useful tactic in determining the significance of a mental problem is for the doctor to interview those close to the patient. Family members and loved ones usually can detect a difference in behaviors in the patient, and for that reason, they can be crucial to helping the doctor to determine if mental decline is present. The doctor will also perform a physical on the patient and inquire about any possible abuses that may cause trauma to the thought process, such as drug usage, alcohol abuse, and head injuries. Blood tests may also be taken to determine if a lack of proper diet is contributing to a person's memory loss as opposed to Alzheimer's disease.
Viewing the structure of the brain can be helpful for doctors in diagnosing Alzheimer's. For that reason, if a doctor suspects that Alzheimer's may be present, they may employ a computed tomography scan or a magnetic resonance imaging scan to view the patient's brain. These tests may not be able to detect the presence of amyloid plaque, but they are efficient when it comes to seeing how the brain operates, which can help a doctor to perform a proper diagnosis.
Once again, diagnoses for Alzheimer's rely on a doctor's intuition and knowledge of the disease. There's no 'smoking gun' when it comes to the disease, and so you must trust your doctor to give you the right information. Alzheimer's is a terrible problem to face, but it's important to get it diagnosed early if you are suspectful. In the disease's later stages, you may be unable to delay the patient's mental decline.
Alzheimer's Disease on the Web
Famous 1848 Case Of A Man Who Survived A Terrible Brain Injury Has Modern Parallel
Poor Phineas Gage. In 1848, the supervisor for the Rutland and Burlington Railroad in Vermont was using a 13-pound, 3-foot-7-inch rod to pack blasting powder into a rock when he triggered an explosion that drove the rod through his left cheek and out of the top of his head. As reported at the time, the rod was later found, "smeared with blood and brains... |
New Clues On How ApoE4 Affects Alzheimer's Risk
Common variants of the ApoE gene are strongly associated with the risk of developing late-onset Alzheimer's disease, but the gene's role in the disease has been unclear. Now, researchers funded by the National Institutes of Health have found that in mice, having the most risky variant of ApoE damages the blood vessels that feed the brain... |
Obama's Grand Plan To Cure Alzheimer's
Obama's healthcare goals have been controversial at best, and although anti-smoking campaigns and other public health and safety awareness drives have been successful, it's always somewhat dubious when government starts creating grand plans and lofty goals... |
Dementia Sufferers More Likely To Die At Home Than In Nursing Homes
A new study from the Regenstrief Institute and Indiana University has found that, at time of death, individuals with dementia are more likely to be living at home than in a nursing home. This contradicts the commonly held view that most individuals with dementia in the United States eventually move to nursing homes and die there... |
Could A Compound Found In Red Wine And Red Grapes Change The Course Of Alzheimer's Disease?
A national, phase II clinical trial examining the effects of resveratrol on individuals with mild to moderate dementia due to Alzheimer's disease has begun as more than two dozen academic institutions recruit volunteers in the coming months. R. Scott Turner, M.D., Ph.D., director of Georgetown University Medical Center's Memory Disorders Program, is the lead investigator for the national study... |
Memory Improved In Amnestic Mild Cognitive Impairment By Reducing Excess Brain Activity
Research published by Cell Press in the journal Neuron, describes a potential new therapeutic approach for improving memory and modifying disease progression in patients with amnestic mild cognitive impairment. The study finds that excess brain activity may be doing more harm than good in some conditions that cause mild cognitive decline and memory impairment... |
Middle Aged And Elderly With Depression Have Higher Risk Of Dementia
A report in the May issue of Archives of General Psychiatry draws a link between people in mid-life and late-life, suffering from depression and the possibility of them developing dementia. More than five million people in the US alone suffer from Alzheimer's disease, and the health care costs run at a staggering $172 Billion. Deborah E. Barnes, Ph.D., M.P.H... |
Memantine Improves Some Alzheimer's Symptoms But Has No Effect On Agitation
A drug prescribed for Alzheimer's disease does not ease clinically significant agitation in patients, according to a new study conducted by researchers from the U.K., U.S. and Norway. This is the first randomized controlled trial designed to assess the effectiveness of the drug (generic name memantine) for significant agitation in Alzheimer's patients... |
Discovery Of Potential Trigger For Alzheimer's Disease
A highly toxic beta-amyloid - a protein that exists in the brains of Alzheimer's disease victims - has been found to greatly increase the toxicity of other more common and less toxic beta-amyloids, serving as a possible "trigger" for the advent and development of Alzheimer's, researchers at the University of Virginia and German biotech company Probiodrug have discovered... |
Too Early To Promote Smell Test For Alzheimer's
A study published online in The Laryngoscope reveals that current studies do not support the use of olfactory identification tests (smell tests) for predicting Alzheimer's dementia. Alzheimer's is a progressive disease that causes loss of brain function and is the most common cause of dementia. The disease is expected to double every 20 years through the year 2040... |
Helping Patients With Dementia Live Well
Care Services Minister Paul Burstow unveiled a range of new design prototypes at the Design Council that can help people with dementia to live well, which included a fragrance-release system designed to stimulate appetite, specially-trained 'guide dogs for the mind' and an intelligent wristband that supports people with dementia to stay active safely... |
Strong Support Uncovered For Once-Marginalized Theory On Parkinson's Disease
University of California, San Diego scientists have used powerful computational tools and laboratory tests to discover new support for a once-marginalized theory about the underlying cause of Parkinson's disease. The new results conflict with an older theory that insoluble intracellular fibrils called amyloids cause Parkinson's disease and other neurodegenerative diseases... |
'Use It Or Lose It' - Protecting Your Brain
The findings of a new study suggest that the protective effects of an active cognitive lifestyle arise through multiple biological pathways. For some time researchers have been aware of a link between what we do with our brains and the long term risk for dementia. In general, those who are more mentally active or maintain an active cognitive lifestyle throughout their lives are at lower risk... |
|